ERG and prostate carcinoma: Somatically, TMPRSS2 is part of the most recurrent aberration known in prostate tumors, the TMPRSS2:ERG (T2E) gene fusion20; however, the association of its heritable cis-regulatory elements with prostate cancer development is novel.